These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32870922)

  • 1. Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran.
    Noel G; Badmasti F; Nikbin VS; Zahraei SM; Madec Y; Tavel D; Aït-Ahmed M; Guiso N; Shahcheraghi F; Taieb F
    PLoS One; 2020; 15(9):e0238398. PubMed ID: 32870922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia.
    Kurova N; Timofeeva EV; Guiso N; Macina D
    Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of pertussis antibodies in 6-17-year-old students in Ahvaz, south-west Islamic Republic of Iran.
    Shamsizadeh A; Nikfar R; Yusefi H; Abbasi-Montazeri E; Cheraghian B
    East Mediterr Health J; 2014 Oct; 20(10):623-6. PubMed ID: 25356693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].
    Seçkin H; Ormeci AR; Sandal G; Kaya S
    Mikrobiyol Bul; 2013 Jul; 47(3):507-13. PubMed ID: 23971928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulation of Bordetella pertussis in vaccinated Cambodian children: A transversal serological study.
    Noel G; Borand L; Leng C; Keang C; Botr C; Dim B; Kerleguer A; Peng YS; Sreng N; Ork V; Ait-Ahmed M; Guiso N; Taieb F
    Int J Infect Dis; 2021 May; 106():134-139. PubMed ID: 33766688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].
    Özbek ÖA; Öktem İMA; Hekimoğlu CH; Sekreter Ö; Emek M; Atasoylu G; Açıkgöz A; Demirpençe N; Ceylan A; Baykal ES; Ünal B
    Mikrobiyol Bul; 2018 Apr; 52(2):180-189. PubMed ID: 29933735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.
    van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM
    Front Immunol; 2018; 9():51. PubMed ID: 29416544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
    Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
    Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan.
    Lu CY; Tsai HC; Huang YC; Huang DT; Liu CC; Huang LM;
    Pediatr Infect Dis J; 2017 Dec; 36(12):e307-e312. PubMed ID: 28737625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of pertussis antitoxin (anti-PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program.
    Hallander HO; Andersson M; Gustafsson L; Ljungman M; Netterlid E
    APMIS; 2009 Dec; 117(12):912-22. PubMed ID: 20078557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination.
    van der Lee S; Sanders EAM; Berbers GAM; Buisman AM
    Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anti-pertussis toxin ELISA and agglutination assays to assess immune responses to pertussis.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Infect Dis (Lond); 2017 Aug; 49(8):594-600. PubMed ID: 28335677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
    Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
    Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.
    Wanlapakorn N; Ngaovithunvong V; Thongmee T; Vichaiwattana P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(2):e0148338. PubMed ID: 26837004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.